Dibutyl ether (stabilised with BHT), 99.0%, 500ml

1-oxa-8-azaspiro[4.5]decan-3-ol, 95.0%, 1g

3-Methyl-quinoxaline-2-carboxylic acid, 95.0%, 5g

3-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)CYCLOHEX-2-ENONE, 95.0%, 25g

(S)-1,3-Dihydrospiro[indene-2,4'-piperidin]-1-amine dihydrochloride, 97%, 1g

2,4-Dichloro-5-methylquinoline, 250mg

Pyridine-2-azo-p-dimethylaniline>98.0%(HPLC)(T)1g

L-1,2,3,4-Tetrahydroisoquinoline-3-carboxylic acid, 98.0%, 5g

7-Chloro-4-methylpyrido[3,4-d]pyridazin-1(2H)-one, 98%, 1g

(4-Amino-3-ethoxyphenyl)(4-(4-methylpiperazin-1-yl)piperidin-1-yl)methanone, 98%, 100mg

Ethyl [2-(pyrimidin-2-ylamino)-thiazol-4-yl]-acetate, 96.0%, 1g

METHYL 3-([(TERT-BUTOXY)CARBONYL]AMINO)BICYCLO[1.1.1]PENTANE-1-CARBOXYLATE, 95.0%, 5g

10-ACETYL-3,7-DIHYDROXYPHENOXAZINE, 95%, 50mg